MagicMed’s Psybrary(TM) Provides the Building Blocks for the Psychedelics Industry to Develop New Patented Pharmaceutical and Consumer Goods Products.
Whitefish, Montana–(Newsfile Corp. – July 14, 2020) – CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD, and psychedelics industries, today announced the addition of MagicMed Industries Inc. to its growing psychedelics client roster.
To view an enhanced version of this logo, please visit:
CFN Media will leverage its proprietary digital content platform and extensive distribution, including its PsyIndex.com, to attract qualified retail, accredited and professional investors to MagicMed Industries.
“The potential for psychedelic medicine has become abundantly clear, but the pharmaceutical industry needs ways to scientifically engineer novel versions of natural psychedelic molecules to improve therapeutic benefit and reduce side effects,” said CFN Media President Frank Lane. “MagicMed’s Psybrary™ aims to fill this key gap in the industry and we look forward to helping them bring their message to potential investors everywhere.”
MagicMed intends to partner with pharmaceutical and other companies to develop psychedelic-derived medicinal and licit consumer goods products. The company’s molecular derivatives library, Psybrary™, is anticipated to be an essential building block from which the industry can develop new patented products. The initial focus is on psilocybin with expansion potential into MDMA, ketamine, ibogaine, mescaline and ayahuasca.
“We are excited to work with CFN Media,” stated Dr. Joseph Tucker, CEO of MagicMed. “The MagicMed team has developed considerable depth and experience together over the prior near decade collaborating with biotech and pharma partners on development and commercialization programs for plant-sourced controlled substances and their novel derivatives. We are now open for business to partner with collaborators in the psychedelic-derived pharmaceuticals field and look forward to the broader reach of that message afforded by this relationship with CFN Media.”
About MagicMed Industries Inc.
MagicMed Industries intends to partner with pharmaceutical and other companies to develop psychedelic-derived medicinal and licit consumer goods products. MagicMed’s molecular derivatives library, the Psybrary™ is anticipated to be an essential building block from which industry can develop new patented products. The initial focus of the Psybrary™ is on psilocybin and is expected to be opportunistically expanded to other psychedelics like MDMA, ketamine, ibogaine, mescaline, and ayahuasca. For more information, please visit our website at www.magicmedindustries.com.
About CFN Enterprises Inc.
CFN Enterprises Inc. (OTCQB: CNFN) is a digital media and ecommerce company focused on advancing businesses and brands in highly regulated emerging industries across the globe. CFN connects investors with new market opportunities while helping consumers find innovative products that enhance their lives. Learn more at www.cfnenterprisesinc.com.
CFN Enterprises Inc. Media Contact:
CFN Enterprises Inc.
+001 (833) 420-CNFN
Use of Forward-looking Statements
This press release may contain forward-looking statements from CFN Enterprises Inc. within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and federal securities laws. For example, when CFN Enterprises Inc. describes the potential acquisition of BarNone assets and the related benefits, its pursuit of M&A opportunities, growth in CBD sales and spending on affiliate marketing, and uses other statements containing the words “believes,” “anticipates,” “plans,” “expects,” “will” and similar expressions, CFN Enterprises Inc. is using forward-looking statements. These forward-looking statements are based on the current expectations of the management of CFN Enterprises Inc. only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: regulatory and licensing risks; changes in general economic, business and political conditions, including changes in the financial markets; the regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; changes in applicable laws; compliance with extensive government regulation; public opinion and perception of the cannabis industry; we may be unable to retain or attract key employees whose knowledge is essential to the development of our products and services; or, loss of market share and pressure on pricing resulting from competition, which could cause the actual results or performance of CFN Enterprises Inc. to differ materially from those contemplated in such forward-looking statements. Except as otherwise required by law, CFN Enterprises Inc. undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. For a more detailed description of the risk and uncertainties affecting CFN Enterprises Inc., reference is made to CFN Enterprises Inc.’s reports filed from time to time with the Securities and Exchange Commission.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/59552